Our vendor and supplier mapping project illustrates the biopharmaceutical industry's investment in our state economies and in the health of the patients we serve.
NJ at a Glance
We Work for Health of New Jersey seeks to educate our elected leaders, the news media and the communities they serve about the important contributions these companies and their employees make to the health and economic security of individuals, local communities, and to the state of New Jersey.
New Jersey life sciences companies maintained 15,772 vendor relationships and purchased more than $8.1 billion worth of goods and services from thousands of local New Jersey businesses stretching from Sussex to Cape May. The state’s biopharmaceutical companies stand together with our business and community partners to educate elected leaders on critical public policy issues that allow our sector, and the surrounding community.
Daniel J. Hayes, Mayor of Bridgewater Township and member of the Mayors Committee on Life Sciences, wrote an op-ed warning of the threat to innovation from proposed changes to Medicare Part B and Part D.
Debra Wentz, Executive Director of the New Jersey Association of Mental Health and Addiction Agencies (NJAMHAA) penned an op-ed on Medicare Part D benefit.
Lisa Yourman, Coalition Chair of Action CF and Co Chair of We Work for Health New Jersey, explains how price controls would hurt patients in this op-ed published by the Courier-Post.
Joseph Tempesta, Jr. explains why the so-called Innovation Act would actually undermine research. Mr. Tempesta is the Mayor of West Caldwell and a member of the Mayors Committee on Life Sciences.
- 9,378 vendor relationships
- $6,484,141,474 vendor spending
- Do you really know what drug importation would mean for #NewJersey? Learn the facts in Mayor Joseph Pannullo oped: https://t.co/dlwYOTxMGR
3 hours ago
- Attending a timely discussion on ACA Repeal & Replace #njpostaca @FrankPallone https://t.co/kPNtkxd2C1
3 days ago
- Learn how drug importation threatens NJ's economy & life science innovation in op-ed from co-chair Joseph Pannullo: https://t.co/NKT4xquAPz
4 days ago
Action CF seeks to advance the public's awareness of the genetic disease Cystic Fibrosis and provide the tools necessary to advocate for pharmaceutical access for patients and research.Learn More